Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.058%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: FTSE 100 at three-week high after policy meetings

Thu, 05th Sep 2013 17:03

A host of central-bank policy meetings, a dovish tone from Mario Draghi and the continued improvement in US economic data helped lift stocks higher on Thursday, with the FTSE 100 closing at levels not seen in three weeks.London's benchmark index ended the day up 57.7 points at 6,532.44, its highest level since August 14th when it finished at 6,587.43."European equities are enjoying the continued central-bank activism of low interest rates environment sticking around for the foreseeable future," said Market Strategist Ishaq Siddiqi from ETX Capital.The Bank of Japan, Bank of England and European Central Bank (ECB) all decided to keep interest rates on hold and current stimulus measures in place on Thursday. However, stocks extended gains in the afternoon after ECB President Mario Draghi struck a dovish tone in a press conference following the bank's decision, saying that the Governing Council had even discussed a rate cut at this month's meeting but decided against it. Draghi did however raise his expectations for Eurozone growth for this year.A barrage of US economic data came in better than expected this afternoon, supporting the call for the Federal Reserve to begin tapering asset purchases at its next meeting later this month - jobless claims fell more than forecasts, factory orders declined less than expected and the ISM non-manufacturing index smashed estimates.However, given that the Fed has explicitly said that the labour market is a key factor in its decision, analysts will be watching the August employment report - due out on Friday afternoon - very carefully. Consensus estimates are for a 180,000 increase in non-farm payrolls last month, up from the 162,000 gain in July. The unemployment rate is expected to remain unchanged at 7.4%, though this has already fallen speedily from 7.9% in January.Meanwhile, the G20 meeting which began in St Petersburg today was likely on the back of investors' minds, given that a potential US military strike in Syria is expected to be the hot topic amongst world leaders. Michael Hewson, Senior Market Analyst at CMC Markets, said: "while there may not be much in the way of fireworks we could well see a lot of tension, given the opposing views of the US and Russia, over the rationale for any type of intervention."FTSE 100: M&S leaps after HSBC upgradeHigh Street department store Marks & Spencer surged today after HSBC upgraded the stock from 'neutral' to 'overweight', saying it is the most operationally geared among its peers to play on the UK consumer recovery.Hotels group IHG was also a high riser after UBS raised its rating from 'neutral to 'buy' and added the stock to its 'Most Preferred' list. The Swiss bank highlighted alleviated concerns about pipeline after the company added more rooms in the first half and also pointed to improving growth in China and continued strength in the US.Decent August traffic statistics from airline peers easyJet and IAG over the last 24 hours have helped both stocks rebound today after falling heavily yesterday on the back of a profit warning from Ryanair, Europe's largest low-cost carrier.Banks were also performing well with Lloyds, Standard Chartered, HSBC, RBS and Barclays all registering decent gains. Lloyds was being helped higher by reports that the Treasury could delay the sale of its 39% stake until later this year because of ongoing tensions in the Middle East and the Fed's taper plan.Meanwhile, food groups Tate & Lyle and AB Foods were lower after Credit Suisse highlighted concerns about sugar prices falling sooner and more steeply than expected.Pharmaceuticals group GlaxoSmithKline was also in the red after announcing a setback on its potential new skin-cancer treatment during clinical trials.FTSE 100 - RisersPersimmon (PSN) 1,152.00p +3.69%Marks & Spencer Group (MKS) 494.90p +3.38%ITV (ITV) 174.60p +3.07%Lloyds Banking Group (LLOY) 74.77p +2.95%International Consolidated Airlines Group SA (CDI) (IAG) 299.40p +2.89%Kingfisher (KGF) 405.80p +2.86%GKN (GKN) 346.60p +2.70%Standard Chartered (STAN) 1,472.50p +2.58%Wolseley (WOS) 3,383.00p +2.52%Rolls-Royce Holdings (RR.) 1,147.00p +2.50%FTSE 100 - FallersTate & Lyle (TATE) 799.50p -1.60%Croda International (CRDA) 2,607.00p -1.25%GlaxoSmithKline (GSK) 1,652.50p -0.81%British Sky Broadcasting Group (BSY) 851.50p -0.76%Associated British Foods (ABF) 1,829.00p -0.65%G4S (GFS) 254.40p -0.62%Antofagasta (ANTO) 881.00p -0.56%Bunzl (BNZL) 1,365.00p -0.44%Aggreko (AGK) 1,599.00p -0.37%Admiral Group (ADM) 1,260.00p -0.32%FTSE 250 - RisersICAP (IAP) 400.00p +6.70%Dixons Retail (DXNS) 46.88p +5.92%Supergroup (SGP) 1,227.00p +5.87%Imagination Technologies Group (IMG) 279.30p +5.68%Tullett Prebon (TLPR) 382.40p +5.29%Home Retail Group (HOME) 152.50p +5.03%Halfords Group (HFD) 381.00p +4.01%Rentokil Initial (RTO) 107.50p +3.97%Hochschild Mining (HOC) 277.90p +3.89%Galliford Try (GFRD) 1,015.00p +3.73%FTSE 250 - FallersBumi (BUMI) 213.40p -2.87%Countrywide (CWD) 550.00p -2.65%BH Macro Ltd. EUR Shares (BHME) € 20.62 -2.51%Rank Group (RNK) 153.10p -2.48%Dairy Crest Group (DCG) 490.60p -2.17%Ted Baker (TED) 1,920.00p -2.14%esure Group (ESUR) 228.50p -1.93%International Public Partnerships Ltd. (INPP) 128.60p -1.83%NMC Health (NMC) 323.00p -1.79%Enterprise Inns (ETI) 143.40p -1.71%BC
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.